Is a complete NSE/INDRAMEDCO research report available?

No complete published report is available for nse/INDRAMEDCO (NSE/INDRAMEDCO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/INDRAMEDCO stock profile: metrics, valuation and analysis

Market cap	32.5B
Revenue (ttm)	15.2B
Net income (ttm)	1.9B
EPS (ttm)	₹20.5
Shares out	91.7M
P/E (trailing)	17.3x
P/E (forward)	15.5x
Dividend	₹4.00 (1.13%)
Volume	185,247
Beta	0.43

All NSE/INDRAMEDCO indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

INR

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	3,035
Employees Change	58%
Employees Change Percent	1.95
Enterprise value	INR 30.3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Care Facilities
Industry PE	73.8
Industry PE Fwd	48.42
Isin	INE681B01017
Last refreshed	2026-09-12
Market cap	INR 32.5B
Price	INR 355
Price currency	INR
Rev Per Employee	5,078,666.67x
Sector	Healthcare
Sector PE	48.04
Sector PE Fwd	38.4
Sic	8062
Symbol	nse/INDRAMEDCO
Website	https://www.apollohospitals.com/delhi/

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.78%
EV Earnings	16.11x
EV/EBIT	13.26x
EV/EBITDA	11.1x
EV/FCF	28.09x
EV/Sales	1.99x
FCF yield	3.31%
Forward P/E	15.48x
P/B ratio	4.4x
P/E ratio	17.31x
P/S ratio	2.14x
PE Ratio10 Y	22.07x
PE Ratio3 Y	20.61x
PE Ratio5 Y	16.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.99%
EBITDA Margin	17.91%
FCF margin	7.27%
Gross margin	36.86%
Gross Profit	INR 5.6B
Gross Profit Growth	12.02%
Gross Profit Growth Q	8.95%
Gross Profit Growth3 Y	12.03%
Gross Profit Growth5 Y	19.03%
Net Income	INR 1.9B
Net Income Growth	12.12%
Net Income Growth Q	8.53%
Net Income Growth Qo Q	33.93%
Net Income Growth Quarters	23%
Net Income Growth Years	5%
Net Income Growth3 Y	24.95%
Net Income Growth5 Y	34.35%
Pretax Margin	16.57%
Profit Margin	12.34%
Profit Per Employee	INR 626,700
Profitable Quarters	INR 24
Profitable Years	21
Roa5y	14.38
Roe5y	26.08
ROIC	32.98
Roic5y	37.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	22.58%
Cagr15y	19.66%
Cagr1y	-29.01%
Cagr20y	15.2%
Cagr3y	30.61%
Cagr5y	36.03%
Div CAGR10	8.31%
Div CAGR3	10.06%
Div CAGR5	9.86%
EPS Growth	12.14
EPS Growth Q	8.56
EPS Growth Qo Q	33.85
EPS Growth Quarters	17
EPS Growth Years	5
EPS Growth3 Y	24.92
EPS Growth5 Y	34.8
FCF Growth	-10.49%
FCF Growth3 Y	2.57%
FCF Growth5 Y	79.1%
OCF Growth	6.82%
OCF Growth10 Y	10.4%
OCF Growth3 Y	5.04%
OCF Growth5 Y	44.25%
Revenue Growth	10.92x
Revenue Growth Q	11.26x
Revenue Growth Qo Q	11.33x
Revenue Growth Quarters	22x
Revenue Growth Years	5x
Revenue Growth3 Y	10.09x
Revenue Growth5 Y	16.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 2.6B
Debt	INR 368.6M
Debt EBITDA	INR 0.14
Debt Equity	INR 0.05
Debt FCF	INR 0.34
Equity	INR 7.4B
Interest Coverage	37.38
Net Cash	INR 2.3B
Net Cash By Market Cap	INR 6.96
Net Cash Growth	-21.64%
Net Debt EBITDA	INR -0.83
Net Debt Equity	INR -0.31
Net Debt FCF	INR -2.1
Tangible Book Value	INR 7.4B
Tangible Book Value Per Share	INR 80.75
WACC	6.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%
Dividend Growth	-11.11%
Dividend Growth Years	0%
Dividend per share	INR 4
Dividend Years	5
Dividend Yield	1.13%
Ex Div Date	2026-09-18
Last Dividend	INR 4
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	665.75%
1Y total return	-28.99%
200-day SMA	401.1
3Y total return	122.83%
50-day SMA	369.2
50-day SMA vs 200-day SMA	50under200
5Y total return	365.71%
All Time High	640.9
All Time High Change	-44.6%
All Time High Date	2025-11-06
All Time Low	5
All Time Low Change	7,000%
All Time Low Date	1998-10-15
ATR	8.85
Beta	0.43
Beta1y	0.51
Beta2y	0.53
Ch YTD	-20.78
High	356.2
High52	640.9
High52 Date	2025-11-06
High52ch	-44.6%
Low	344.1
Low52	342
Low52 Date	2026-01-27
Low52ch	3.8%
Ma50ch	-3.85%
Price vs 200-day SMA	-11.49%
RSI	41.27
RSI Monthly	47.89
RSI Weekly	40.38
Sharpe ratio	-0.58x
Sharpe Ratio3y	0.7x
Sharpe Ratio5y	0.86x
Sortino ratio	-0.75
Sortino Ratio3y	1.32
Sortino Ratio5y	1.58
Total Return	1.14%
Tr YTD	-20.78
Tr15y	1,377.11%
Tr1m	-9.15%
Tr1w	-0.38%
Tr3m	-6.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40,082,258%
Net Borrowing	-24,300,000
Shares Insiders	2.9%
Shares Institutions	5.1%
Shares Out	91,673,000
Shares Qo Q	0.06%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	176,549x
Bv Per Share	80.78
CAPEX	INR -596.5M
Ch10y	539.6
Ch15y	920.1
Ch1m	-9.15
Ch1w	-0.38
Ch1y	-29.65
Ch20y	855.6
Ch3m	-6.78
Ch3y	114.6
Ch5y	333.2
Ch6m	-12.15
Change	-1.39%
Change From Open	2.9
Close	360
Days Gap	-4.17
Depreciation Amortization	445,200,000
Dollar Volume	65,762,685
Earnings Date	2026-11-03
EBIT	INR 2.3B
EBITDA	INR 2.7B
EPS	INR 20.51
F Score	3
FCF	INR 1.1B
FCF EV Yield	3.56x
FCF Per Share	INR 11.76
Financing CF	-463,800,000
Fiscal Year End	March
Founded	1,983
Graham Number	193.07984
Graham Upside	-45.61
Income Tax	INR 645.2M
Investing CF	-1,776,100,000
Is Primary Listing	1
Last Earnings Date	2026-08-06
Last Report Date	2026-06-30
Lynch Fair Value	INR 513
Lynch Upside	44.44
Ma150	387.8
Ma150ch	-8.46%
Ma20	363.6
Ma20ch	-2.37%
Net CF	-565,500,000
Next Earnings Date	2026-11-03
Open	345
P FCF Ratio	30.19
P OCF Ratio	19.44
Payment Date	2026-10-24
Position In Range	90.08
Price Date	2026-09-11
Price EBITDA	INR 11.93
Ptbv Ratio	4.4
Relative Volume	1.06x
Revenue	15,236,000,000x
Tax By Revenue	4.23x
Tax Rate	25.55%
Tr20y	1,594.95%
Tr6m	-12.15%
Volume	185,247

NSE/INDRAMEDCO (NSE/INDRAMEDCO)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/INDRAMEDCO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/INDRAMEDCO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/INDRAMEDCO

Frequently asked questions